3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
3
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
cabozantinib
5
Nivolumab
4
Ipilimumab
4
Axitinib
4
pembrolizumab
3
Blood Specimen Collection
3
zimberelimab
2
atezolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Irinotecan
2
temsirolimus
1
spartalizumab
1
salicylhydroxamic acid
1
palbociclib
1
orellanine
1
olaparib
1
liposomal doxorubicin
1
lenvatinib
1
gallium Ga 68 dotatate
1
fludarabine
1
brodalumab
1
belzutifan
1
aldesleukin
1
adagrasib
1
Vincristine
1
Temozolomide
1
Taxes
1
Selenomethionine
1
Ropivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Biopsy, Large-Core Needle
×
90 days
×
Clear all
NCT05520099
2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
416 enrolled